Evidence map›Paper›PMID 36213837›Full record

ArticleJournal of oncology2022

Characterizing

Xin Jin, Haida Shi, Zhi Li, Huixing Li, Huanxian Ma, Xianjie Shi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Xin JinMedical School of Chinese PLA and Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of PLA General Hospital, Beijing 100853, China.ORCID https://orcid.org/0000-0001-5099-3694
Haida ShiEmergency Department of the Fourth Medical Center of PLA General Hospital, Beijing 100853, China.ORCID https://orcid.org/0000-0001-9665-3601
Zhi LiMedical School of Chinese PLA and Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of PLA General Hospital, Beijing 100853, China.ORCID https://orcid.org/0000-0001-9881-6590
Huixing LiDepartment of Hepatobiliary Surgery, Aerospace Center Hospital, Beijing 100049, China.ORCID https://orcid.org/0000-0003-1448-9022
Huanxian MaDepartment of Critical Care Medicine, Faculty of Hepato-Biliary-Pancreatic Surgery, The First Medical Center of PLA General Hospital, Beijing 100853, China.ORCID https://orcid.org/0000-0002-0128-6480
Xianjie ShiMedical School of Chinese PLA and Department of Hepatobiliary and Pancreatic Surgery, The Eighth Affiliated Hospital of Sun Yat-Sen University, Shenzhen 518033, China.ORCID https://orcid.org/0000-0001-7712-2258
Chinese PLA General Hospital · CNAerospace Center Hospital · CNNanjing General Hospital of Nanjing Military Command · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A large number of cancer-related deaths in the world can be attributed to liver hepatocellular carcinoma (LIHC). The purpose of this study is to explore protein tyrosine phosphatase type IV A member 3 ( Methods: We included three LIHC datasets with clinical information and expression profiles from public databases. The expression level of Results: The expression levels of the LIHC and adjacent samples were analyzed, and it was observed that the expression level of Conclusion:

Identifiers

PMID36213837
PMCPMC9546693
OpenAlexW4298111371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.